Minakem Generic APIs Minakem Generic APIs

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about PTC Therapeutics aggregated by PharmaCompass.com.

    Client Virtual Booth

    PTC THERAPEUTICS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    PTC Therapeutics
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    PTC Therapeutics Inc. 100 Corporate Court South Plainfield, NJ
    Telephone
    Telephone
    + 908-222-7000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ptcbio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ptc-therapeutics/?originalSubdomain=in
    Twitter
    Twitter
    https://twitter.com/ptcbio?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    EU's drug regulator again rejects Apellis' eye med and PTC's Translarna
    EU's drug regulator again rejects Apellis' eye med and PTC's Translarna

    https://www.fiercepharma.com/pharma/chmp-again-rejects-apellis-ga-drug-syfovre-company-will-ask-review

    Kevin Dunleavy FIERCE PHARMA
    02 Jul 2024
    Share Share
    CHMP Issues Negative Opinion On Translarna Following European Commission Review
    CHMP Issues Negative Opinion On Translarna Following European Commission Review

    https://www.prnewswire.com/news-releases/chmp-issues-negative-opinion-on-translarna-following-european-commission-request-for-review-302185263.html

    PR NEWSWIRE
    28 Jun 2024
    Share Share
    PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    https://www.prnewswire.com/news-releases/ptc-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-302177186.html

    PR NEWSWIRE
    21 Jun 2024
    Share Share
    PIVOT-HD Shows Positive 12-Month Biomarker And Clinical Data In Huntington's
    PIVOT-HD Shows Positive 12-Month Biomarker And Clinical Data In Huntington's

    https://www.prnewswire.com/news-releases/interim-pivot-hd-results-demonstrate-evidence-of-favorable-cns-biomarker-and-clinical-effects-at-month-12-in-huntingtons-disease-patients-302177663.html

    PR NEWSWIRE
    20 Jun 2024
    Share Share
    PTC Therapeutics to Participate at Upcoming Investor Conference
    PTC Therapeutics to Participate at Upcoming Investor Conference

    https://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-at-upcoming-investor-conference-302157009.html

    PR NEWSWIRE
    30 May 2024
    Share Share
    PTC Therapeutics Announces Validation of Sepiapterin European MAA
    PTC Therapeutics Announces Validation of Sepiapterin European MAA

    https://www.prnewswire.com/news-releases/ptc-therapeutics-announces-validation-of-sepiapterin-european-maa-302156304.html

    PR NEWSWIRE
    28 May 2024
    Share Share
    PTC gets another chance to keep Translarna's EU authorization
    PTC gets another chance to keep Translarna's EU authorization

    https://www.fiercepharma.com/pharma/third-times-charm-ptc-will-get-another-chance-keep-translarnas-european-marketing

    FIERCE PHARMA
    21 May 2024
    Share Share
    PTC: EU Returns Translarna Opinion To CHMP For Re-Evaluation
    PTC: EU Returns Translarna Opinion To CHMP For Re-Evaluation

    https://www.prnewswire.com/news-releases/ptc-therapeutics-announces-european-commission-returns-translarna-opinion-to-chmp-for-re-evaluation-302150307.html

    PR NEWSWIRE
    20 May 2024
    Share Share
    PTC Announces FDA Acceptance, Priority Review Of Upstaza BLA
    PTC Announces FDA Acceptance, Priority Review Of Upstaza BLA

    https://www.prnewswire.com/news-releases/ptc-therapeutics-announces-fda-acceptance-and-priority-review-of-the-bla-for-upstaza-302144369.html

    PR NEWSWIRE
    14 May 2024
    Share Share
    PTC Therapeutics to Participate at Upcoming Investor Conferences
    PTC Therapeutics to Participate at Upcoming Investor Conferences

    https://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-at-upcoming-investor-conferences-302133727.html

    PR NEWSWIRE
    02 May 2024
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    bora-pharmaceuticals-2024-07-01

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search